It is an unsettling question that has emerged alongside the extraordinary rise of the new generation of weight-loss drugs.

Employer coverage of GLP-1 drugs is collapsing heading into 2027, but the FDA just gave Eli Lilly a specific piece of ...

The FDA has approved Mounjaro to reduce cardiovascular risk in people with type 2 diabetes after a major trial found it ...

By Nqobile Dludla JOHANNESBURG, Sept 3 (Reuters) - Aspen Pharmacare expects African sales of Eli Lilly's blockbuster weight-loss and diabetes drug Mounjaro to exceed 2 billion rand ($124 million) in ...

(This Aug 28 story has been repeated with no changes to text.) Aug 28 (Reuters) - Eli Lilly said on Friday the U.S. FDA has ...

For decades, type 2 diabetes was managed with medicines that either pushed insulin higher or improved how the body used it.

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and medical device regulation, and what we’re reading from around the web. Several ...

The active ingredient in Truxima is rituximab-abbs. (The active ingredient is what makes a drug work.) It belongs to a group of drugs called monoclonal antibodies, and it’s a kind of immunotherapy.